As of Apr 28
| -0.60 / -0.46%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 137.50, with a high estimate of 170.00 and a low estimate of 118.00. The median estimate represents a +5.51% increase from the last price of 130.32.
The current consensus among 9 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.